Bottom line
FTXH vs LYFIX: the short answer
FTXH (First Trust Nasdaq Pharmaceuticals ETF) and LYFIX (AlphaCentric Life Sciences and Healthcare Fund) are quite different portfolios: only about 22% of their top holdings (by weight) are shared.
FTXH is cheaper at 0.6% vs 1.41% — a difference of $81 a year per $10,000 invested.
Over five years, FTXH returned +6.5% a year vs +5.6% for LYFIX.
Updated Nov 19, 2026
FTXH vs LYFIX side by side
| FTXH | LYFIX | |
|---|---|---|
| Type | ETF | Mutual fund |
| Fund family | First Trust | Mutual |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 0.6% | 1.41% |
| Annual cost per $10k | $60 | $141 |
| 10-yr cost on $10k (prospectus) | — | $2,357 |
| Max front load | None | 0% |
| 12b-1 fee | 0% | 0% |
| 1-yr return | +24.0% | +28.2% |
| 5-yr return (annualized) | +6.5% | +5.6% |
| 10-yr return (annualized) | — | — |
| Best quarter | +18.3% | +27.5% |
| Worst quarter | −17.4% | −11.9% |
| Net assets (fund) | $36.2M | $46.6M |
| Number of holdings | 51 | 62 |
| Portfolio turnover | 35% | 107% |
| Returns as of | Dec 31, 2025 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Holdings overlap
8 of FTXH's top 25 holdings also appear in LYFIX's top 25.
| Holding | FTXH | LYFIX |
|---|---|---|
| Abbvie Inc | 7.39% | 1.95% |
| Biogen Inc | 3.84% | 1.80% |
| Vertex Pharmaceuticals Inc | 3.41% | 5.33% |
| Amgen Inc | 3.18% | 1.83% |
| Gilead Sciences Inc | 2.89% | 5.53% |
| Incyte Corp | 2.39% | 3.51% |
| Neurocrine Biosciences Inc | 1.37% | 3.51% |
| Halozyme Therapeutics Inc | 1.21% | 1.58% |
Source: SEC Form N-PORT
FTXH top 10
- Eli Lilly & Company — 7.77%
- Abbvie Inc — 7.39%
- Merck & Company Inc — 7.07%
- Johnson & Johnson — 6.96%
- Bristol-myers Squibb Company — 6.29%
- Biogen Inc — 3.84%
- Viatris Inc — 3.62%
- Cardinal Health Inc — 3.53%
- Vertex Pharmaceuticals Inc — 3.41%
- Amgen Inc — 3.18%
LYFIX top 10
- Gilead Sciences Inc — 5.53%
- Vertex Pharmaceuticals Inc — 5.33%
- Astrazeneca Plc — 4.63%
- First American Funds Inc — 4.26%
- Roivant Sciences Ltd — 3.67%
- Argenx Se — 3.59%
- Neurocrine Biosciences Inc — 3.51%
- Incyte Corp — 3.51%
- Axsome Therapeutics Inc — 3.43%
- Apogee Therapeutics Inc — 3.28%
FAQ
What is the difference between FTXH and LYFIX?
Which is cheaper, FTXH or LYFIX?
Should I own both FTXH and LYFIX?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.